• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受法布里病影响的家族中的听力损失。

Hearing loss in a family affected by Fabry disease.

作者信息

Sergi Bruno, Conti Guido

机构信息

Clinic of Otorhinolaryngology, Catholic University of Scared Heart of Rome, Largo F Vito 1, 00168, Rome, Italy.

出版信息

J Inherit Metab Dis. 2007 Jun;30(3):370-4. doi: 10.1007/s10545-007-0523-0. Epub 2007 May 9.

DOI:10.1007/s10545-007-0523-0
PMID:17487569
Abstract

Fabry disease is an inborn error of metabolism due to deficient activity of the lysosomal enzyme alpha-galactosidase A. The enzyme defect leads to the systemic accumulation of neutral glycosphingolipids in tissues. Otological manifestations consist of hearing loss and mild vestibular disorders. In this report we describe a family of five members affected by Fabry disease with four subjects showing inner ear involvement.

摘要

法布里病是一种由于溶酶体酶α-半乳糖苷酶A活性缺乏导致的先天性代谢紊乱。该酶缺陷导致中性糖鞘脂在组织中系统性蓄积。耳部表现包括听力损失和轻度前庭功能障碍。在本报告中,我们描述了一个五口之家受法布里病影响,其中四名受试者存在内耳受累情况。

相似文献

1
Hearing loss in a family affected by Fabry disease.受法布里病影响的家族中的听力损失。
J Inherit Metab Dis. 2007 Jun;30(3):370-4. doi: 10.1007/s10545-007-0523-0. Epub 2007 May 9.
2
[The cochlea in Fabry disease: a sensorineural hearing loss model of vascular origin?].[法布里病中的耳蜗:血管源性感音神经性听力损失模型?]
Rev Med Interne. 2006 Jul;27(7):527-31. doi: 10.1016/j.revmed.2005.12.006. Epub 2006 Jan 6.
3
Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.法布里病的听觉和前庭表现:对半合子男性和杂合子女性的一项研究。
Acta Paediatr Suppl. 2003 Dec;92(443):33-7; discussion 27. doi: 10.1111/j.1651-2227.2003.tb00219.x.
4
Normal hearing in alpha-galactosidase A-deficient mice, the mouse model for Fabry disease.α-半乳糖苷酶A缺乏小鼠(法布里病的小鼠模型)的正常听力。
Hear Res. 2007 Dec;234(1-2):10-4. doi: 10.1016/j.heares.2007.08.009. Epub 2007 Sep 14.
5
[Fabry disease. Clinical and genetic aspects. Therapeutic perspectives].[法布里病。临床与遗传学方面。治疗前景]
Rev Med Interne. 2000 Dec;21(12):1086-103. doi: 10.1016/s0248-8663(00)00269-1.
6
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.伴有严重心脏表现的法布里病患者新型α-半乳糖苷酶 A 突变。
Gene. 2014 Feb 10;535(2):365-9. doi: 10.1016/j.gene.2013.09.058. Epub 2013 Oct 17.
7
Clinical, histological and molecular characteristics of Mexican patients with Fabry disease and significant renal involvement.墨西哥伴有显著肾脏受累的法布里病患者的临床、组织学和分子特征。
Arch Med Res. 2014 Apr;45(3):257-62. doi: 10.1016/j.arcmed.2014.03.005. Epub 2014 Mar 20.
8
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.法布里病听力损失的神经病变和脑血管相关性
Brain. 2007 Jan;130(Pt 1):143-50. doi: 10.1093/brain/awl310. Epub 2006 Nov 14.
9
Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.法布里病:新型α-半乳糖苷酶A突变的鉴定及通过荧光化学错配切割进行分子携带者检测
Biochem Biophys Res Commun. 1999 Apr 21;257(3):708-13. doi: 10.1006/bbrc.1999.0310.
10
[Fabry disease: data from four families].[法布里病:来自四个家族的数据]
Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2412-5.

引用本文的文献

1
The vestibular and oculomotor dysfunction in Fabry disease: a cohort study in China.法布里病的前庭和动眼功能障碍:一项中国的队列研究。
Ann Med. 2025 Dec;57(1):2453626. doi: 10.1080/07853890.2025.2453626. Epub 2025 Jan 25.
2
Cochleovestibular Signs As the First Manifestation of Fabry Disease: A Case Report and Literature Review.以耳蜗前庭症状为首发表现的法布里病:1例报告及文献复习
Cureus. 2024 Mar 30;16(3):e57289. doi: 10.7759/cureus.57289. eCollection 2024 Mar.
3
Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease.

本文引用的文献

1
Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey.阿加糖酶α与法布里病的听力:来自法布里病结局调查的数据。
Eur J Clin Invest. 2006 Sep;36(9):663-7. doi: 10.1111/j.1365-2362.2006.01701.x.
2
Hearing loss in Fabry disease: data from the Fabry Outcome Survey.法布里病中的听力损失:来自法布里病结局调查的数据。
Eur J Clin Invest. 2006 Sep;36(9):654-62. doi: 10.1111/j.1365-2362.2006.01702.x.
3
[The cochlea in Fabry disease: a sensorineural hearing loss model of vascular origin?].[法布里病中的耳蜗:血管源性感音神经性听力损失模型?]
法布里病中的神经耳科学和周围神经受累情况
Audiol Res. 2017 Jul 28;7(2):176. doi: 10.4081/audiores.2017.176. eCollection 2017 Jul 18.
4
Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy.安德森-法布里病中耳受累:酶替代治疗的长期随访。
Acta Otorhinolaryngol Ital. 2010 Apr;30(2):87-93.
Rev Med Interne. 2006 Jul;27(7):527-31. doi: 10.1016/j.revmed.2005.12.006. Epub 2006 Jan 6.
4
Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.法布里病的听觉和前庭表现:对半合子男性和杂合子女性的一项研究。
Acta Paediatr Suppl. 2003 Dec;92(443):33-7; discussion 27. doi: 10.1111/j.1651-2227.2003.tb00219.x.
5
Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy.法布里病中的听力损失:阿加糖酶α替代疗法的效果
J Inherit Metab Dis. 2003;26(8):787-94. doi: 10.1023/B:BOLI.0000009948.86528.72.
6
Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.患有法布里病的患者渐进性听力损失和突发性耳聋的发生率增加:对22名半合子男性患者的调查。
BMC Med Genet. 2002 Oct 11;3:10. doi: 10.1186/1471-2350-3-10.
7
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.安德森-法布里病:60名确诊携带者女性队列中的临床表现及疾病影响
J Med Genet. 2001 Nov;38(11):769-75. doi: 10.1136/jmg.38.11.769.
8
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.安德森-法布里病:98例半合子男性患者队列中的临床表现及疾病影响
J Med Genet. 2001 Nov;38(11):750-60. doi: 10.1136/jmg.38.11.750.
9
Enhanced endothelium-dependent vasodilation in Fabry disease.法布里病中内皮依赖性血管舒张增强。
Stroke. 2001 Jul;32(7):1559-62. doi: 10.1161/01.str.32.7.1559.
10
[Fabry disease. Clinical and genetic aspects. Therapeutic perspectives].[法布里病。临床与遗传学方面。治疗前景]
Rev Med Interne. 2000 Dec;21(12):1086-103. doi: 10.1016/s0248-8663(00)00269-1.